Lecture 11-15 Flashcards
Chemical rxn rate
Always expressed in M/sec
Rate constant
Has units that allow rxn rate to have units on M/sec E + S EX E + P k1 = M-1 x sec-1 k2 = sec-1 k3 = sec-1
Michaelis-Menten assumptions
- [S]tot»_space; [E]tot such that [S]tot = ([S]free + [EX]) = [S]free
- Conservation of enzyme such that [E]tot = [E]free + [EX]
- [P] = 0 throughout measurements such that EX -> E + P is unidirectional
- Enzyme remains fully active throughout measurements
Steady state assumption
d[EX]/dt = 0. Constant flow through each step
v
Initial rate or velocity. v = k3[EX]
Vmax
Maximal rate or velocity. Vmax = k3[E]tot
Michaelis-Menten equation
v = (Vmax)/(1 + Km/[S])
Km
Kinetic parameter that may or may not equal Kd. Km only equals Kd when k2»_space; k3. Gives substrate concentration for rate that is half of Vmax.
Km = (k2+k3)/k1
kcat
Turnover number. The number of product molecules formed by each enzyme active site per second. Frequency of catalysis. True constant that represents catalytic efficiency
Vm = kcat[E]tot
Kd
Thermodynamic parameter and measure of affinity. Lower Kd means higher affinity
Kd = k2/k1
Ordered ternary complex mechanism
Model of how enzymes use two substrates. A binds first and Q leaves last
E + A <> EA + B <> EAB <> EPQ <> EQ + P <> E + Q
Random ternary complex mechanism
Model of how enzymes use two substrates. No compulsory order for substrate addition or release. A or B could bind first and P or Q could leave first. Neither path alters EX and overall catalytic mechanism
Ping pong mechanism
Model of how enzymes use two substrates. Forms covalent rxn intermediate (E-X). Ex: chymotrypsin
E + A <> EA + P <> E-X + B <> E-XB <> E + Q
Stopped-flow apparatus
Designed to use both absorbance and fluorescence detectors to observe multiple rxn intermediates during pre-steady-state phase. Evaluates all rate constants and all “internal” equilibrium constants for a more complete picture of catalysis
Competitive inhibition
Reversible form of inhibition. Inhibitor binds in place of substrate at active site. Raising [S] can fully reverse inhibition. Poor drug model
Noncompetitive inhibition
Reversible form of inhibition. Inhibitor binds at separate site to substrate. Raising [S] cannot fully revers inhibition. Better model for effective drugs
Uncompetitive inhibition
Reversible form of inhibition. Substrate binding creates site for inhibitor binding. Rare inhibitory mode as transition from EX to E+P is fast
Metabolism
Totality of cellular processes that make and degrade chemical substances (metabolites), fueling and facilitating vital processes such as meiosis, locomotion, transport, genetics, evolution, etc
Anabolism
Pathways that synthesize biomolecules form simpler precursor metabolites
Catabolism
Pathways that degrade complex biomolecules yielding energy and/or forming simpler metabolites
Allosteric regulation
Reversible binding of regulatory molecules that alter enzyme conformation and activity (µsec-msec). Activators increase substrate binding/kcat. Inhibitors decrease substrate binding/kcat